Liège implant shows early promise in cluster headache pilot trial
Published 6 h ago1 sourceEvidence: Reported
The FDA approved a bone graft substitute derived from recycled oyster shells, developed in Australia, that converts the material into a compound resembling human bone mineral to promote regeneration of fractures and surgical defects. This marks a novel use of a sustainable raw material in medical devices, though clinical efficacy details and market impact remain unspecified.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 6 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Unknown
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported